David is a corporate lawyer who advises on a wide range of matters including mergers and acquisitions, venture capital financings, spin-outs from universities and research institutions, equity capital markets and corporate restructurings.
David has broad experience working with clients across a range of industries, with a particular focus on transactions in the life sciences and technology sectors. This sector focus has resulted in David regularly advising investors, universities, research institutions and spin-out companies on the equity financing aspects of technology transfer and representing these same clients on subsequent financing rounds. The majority of David’s work has a cross-border or international element.
David joined Bristows in 2009 having previously trained and worked in the London office of a leading US law firm.
David is a CEDR accredited mediator.
Biotech Review of the Year
Read here